Literature DB >> 16483908

Do biochemical markers have a role in osteoarthritis diagnosis and treatment?

Virginia B Kraus1.   

Abstract

It is possible to use biomarkers in cohort studies and in clinical trials to increase our understanding of disease, to elucidate disease mechanisms, and to bolster a clinical impression of the disease state of osteoarthritis. Whether it will be possible to utilize biomarkers meaningfully to characterize the disease state in an individual patient remains to be seen. Major concepts related to the use of biomarkers for research and clinical practice, and factors influencing biomarker concentrations, are described in this review in order to address the potential role of biomarkers in osteoarthritis diagnosis, prognosis, and treatment.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16483908     DOI： 10.1016/j.berh.2005.09.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN： 1521-6942            Impact factor:   4.098


  9 in total

1.  PIIANP and HELIXII diurnal variation.

Authors:  D J Quintana; P Garnero; J L Huebner; N Charni-Ben Tabassi; V B Kraus
Journal:  Osteoarthritis Cartilage       Date:  2008-04-22       Impact factor: 6.576

2.  Personalized medicine for osteoarthritis: where are we now?

Authors:  Allen Dale Sawitzke
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-04       Impact factor: 5.346

3.  The current and future status of biomarkers in osteoarthritis.

Authors:  David T Felson
Journal:  J Rheumatol       Date:  2014-05       Impact factor: 4.666

4.  Biomarkers of incident radiographic knee osteoarthritis: do they vary by chronic knee symptoms?

Authors:  Yvonne M Golightly; Stephen W Marshall; Virginia B Kraus; Jordan B Renner; Andrés Villaveces; Carri Casteel; Joanne M Jordan
Journal:  Arthritis Rheum       Date:  2011-08

5.  Investigation of the Capture of Magnetic Particles From High-Viscosity Fluids Using Permanent Magnets.

Authors:  Alexandra Garraud; Camilo Velez; Yash Shah; Nicolas Garraud; Bettina Kozissnik; Elena G Yarmola; Kyle D Allen; Jon Dobson; David P Arnold
Journal:  IEEE Trans Biomed Eng       Date:  2015-07-20       Impact factor: 4.538

6.  Failure of serum transforming growth factor-beta (TGF-beta1) as a biomarker of radiographic osteoarthritis at the knee and hip: a cross-sectional analysis in the Johnston County Osteoarthritis Project.

Authors:  A E Nelson; F Fang; X A Shi; V B Kraus; T Stabler; J B Renner; T A Schwartz; C G Helmick; J M Jordan
Journal:  Osteoarthritis Cartilage       Date:  2008-11-21       Impact factor: 6.576

7.  Whither osteoarthritis biomarkers?

Authors:  D T Felson; L S Lohmander
Journal:  Osteoarthritis Cartilage       Date:  2009-02-23       Impact factor: 6.576

8.  Relationships between biomarkers of cartilage, bone, synovial metabolism and knee pain provide insights into the origins of pain in early knee osteoarthritis.

Authors:  Muneaki Ishijima; Taiji Watari; Kiyohito Naito; Haruka Kaneko; Ippei Futami; Kaori Yoshimura-Ishida; Akihito Tomonaga; Hideyo Yamaguchi; Tetsuro Yamamoto; Isao Nagaoka; Hisashi Kurosawa; Robin A Poole; Kazuo Kaneko
Journal:  Arthritis Res Ther       Date:  2011-02-14       Impact factor: 5.156

9.  Reference intervals of serum hyaluronic acid corresponding to the radiographic severity of knee osteoarthritis in women.

Authors:  Haruka Kaneko; Muneaki Ishijima; Tokuhide Doi; Ippei Futami; Lizu Liu; Ryo Sadatsuki; Anwarjan Yusup; Shinnosuke Hada; Mitsuaki Kubota; Takayuki Kawasaki; Yoshitomo Saita; Yuji Takazawa; Hiroshi Ikeda; Hisashi Kurosawa; Kazuo Kaneko
Journal:  BMC Musculoskelet Disord       Date:  2013-01-18       Impact factor: 2.362
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.